Yellow wavelength lasers are a new development in the treatment of retinal diseases and hold many advantages over the traditional green wavelength lasers used in the majority of eye units in the UK. They penetrate the tissues of the eye including through cataracts to where they are effective at the retina. This wavelength laser works therapeutically on the retinal tissues, but critically does not cause as much damage as green lasers.
Micropulse technology available with this machine spares surrounding tissues by preventing overheating of adjacent tissues allowing scar free treatments. This is not possible with the green wavelength lasers used in the majority of UK eye units.
The two key features of yellow wavelength light and micropulse delivery makes this laser a significant technological advancement in retinal disease treatment and would be an asset to the Eye Department in Basingstoke.
The machine will be used routinely 3-4 times per week. It may also be used daily to treat emergency cases as the need arises.
In 2015, 135 patients underwent retinal laser procedures in the eye department at BNHH. As the burden of diabetic eye disease increases, this figure is expected to increase year on year.
Benefits of treatments with this machine:
- Fewer hospital visits required for patients undergoing pan retinal photocoagulation (PRP), as speed of treatment means fractionated treatment is not required
- Increased comfort for patients undergoing PRP
- Micropulse mode for macular laser treatment produces no treatment induced scarring. More repeat treatments are possible.
Yellow wavelength laser light is more effective in treating the retina with less damage to adjacent tissues.